Experience with thoratec left ventricular assist device (LVAD) during radiotherapy treatment

被引:0
|
作者
Lasher, D.
Wojcicka, J.
Malcom, R.
Shears, L.
机构
[1] York Canc Ctr, York, N Yorkshire, England
[2] Wellspan Hlth, York, N Yorkshire, England
关键词
D O I
10.1118/1.2760884
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: This poster describes the response of a Thoratec left ventricular assist device (LVAD) to the scatter, leakage, and RF environment in a linear accelerator vault. The device contains a mechanical pump attached to the abdominal wall that the supports left ventricle in circulating blood. Cannulae connect the paracorporeal pump to the ventricle. An electric lead relays pump filling information to the TLC‐II computer‐controlled driver, and a pneumatic lead transfers positive air pressure to the pump and ejects the blood. Method and Materials: The treatment plan was 4500 cGy to the rectum over 25 fractions with three 15MV photon beams on a Varian 2100EX. All beams avoided the pump and leads. The response to EMI was evaluated by observing a duplicate driver in the treatment configuration as the patient's fields were delivered to a 30×18×60cm3 solid water equivalent phantom. Pre‐treatment dose assessment included calculations with Pinnacle treatment planning system, AAPM TG36 data analysis, and MOSFET measurements with high sensitivity bias on the surface of the driver during the phantom irradiation. During the first patient treatment, MOSFETs were placed on the pump and leads under 1cm of bolus, approximately 1cm from the left lateral treatment portal. No additional shielding was applied to the LVAD. Results: EMI interference was absent and the LVAD operated normally during the pre‐treatment test and throughout the treatment course. Radiation to the driver was too low to be detected by the MOSFETS. Cumulative dose estimates to the pump were 425cGy to 0.1cc (DVH), 262.8cGy (TG36), and 158.5cGy (MOSFET). MOSFET readings to the leads were 70.5cGy. Conclusion: External beam radiation treatment was safely delivered to a LVAD dependent patient. The Thoratec TLC‐II exhibited no adverse response to EMI and doses up to 425 cGy. Our results are based on one case and further study is encouraged. © 2007, American Association of Physicists in Medicine. All rights reserved.
引用
收藏
页码:2453 / 2453
页数:1
相关论文
共 50 条
  • [11] Monitoring recovery and weaning from the thoratec left ventricular assist device
    Fernández, AL
    Martínez, A
    ANNALS OF THORACIC SURGERY, 2002, 73 (05): : 1689 - 1689
  • [12] The Thoratec Implantable Ventricular Assist Device (IVAD): Initial clinical experience
    Samuels, Louis E.
    Holmes, Elena C.
    Hagan, Kevin
    Gopalan, Radha
    Droogan, Christopher
    Ferdinand, Francis
    HEART SURGERY FORUM, 2006, 9 (04): : E690 - E692
  • [13] Thoratec Left Ventricular Assist Device Removal After Toxic Myocarditis
    Leontiadis, Evangelos
    Morshuis, Michiel
    Arusoglu, Latif
    Cobaugh, Dagmar
    Koerfer, Reiner
    El-Banayosy, Aly
    ANNALS OF THORACIC SURGERY, 2008, 86 (06): : 1982 - 1985
  • [14] ECG alarms during left ventricular assist device (LVAD) therapy in the ICU
    Watanakeeree, Kevin
    Suba, Sukardi
    Mackin, Lynda A.
    Badilini, Fabio
    Pelter, Michele M.
    HEART & LUNG, 2021, 50 (06): : 763 - 769
  • [15] The thoratec Implantable Ventricular Assist Device (IVAD): Initial clinical experience
    Samuels, Louis E.
    Holmes, Elena C.
    Hagan, Kevin
    Gopalan, Radha
    Droogan, Christopher
    Ferdinand, Francis
    CHEST, 2006, 130 (04) : 188S - 188S
  • [16] Intermediate experience with the Jarvik 2000 axial flow left ventricular assist device (LVAD)
    Haj-Yahya, S. M.
    Birks, E. J.
    Hardy, J.
    Hipkin, M.
    Bowles, C.
    Dreyfus, G.
    Banner, N.
    Khaghani, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02): : S58 - S58
  • [17] Left Ventricular Assist Device (LVAD) in Singapore: A Nation's 10 Year Experience
    Foo, J. J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S393 - S393
  • [18] Left atrial or ventricular cannulation beyond 30 days for a thoratec ventricular assist device
    Holman, William L.
    Bourge, Robert C.
    Murrah, Patrick C.
    McGiffin, David C.
    Spruell, Russell D.
    Ferguson, Edward R.
    Kirklin, James K.
    ASAIO Journal, 1995, 41 (03):
  • [19] Thyroid Function at Left Ventricular Assist Device (LVAD) Implantation Predicts Prognosis During LVAD Support
    Bielka, A. A.
    Kalinowski, M. E.
    Gawlikowski, M.
    Zembala, M. O.
    Przybylowski, P.
    Zembala, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S121 - S122
  • [20] Flap coverage for the treatment of exposed left ventricular assist device (LVAD) hardware and intractable LVAD infections
    Jacoby, Adam
    Stranix, John T.
    Cohen, Oriana
    Louie, Eddie
    Balsam, Leora B.
    Levine, Jamie P.
    JOURNAL OF CARDIAC SURGERY, 2017, 32 (11) : 732 - 737